Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
744,940
-
Share change
-
-75,434
-
Total reported value
-
$171,825
-
Price per share
-
$0.23
-
Number of holders
-
16
-
Value change
-
-$13,831
-
Number of buys
-
5
-
Number of sells
-
4
Institutional Holders of VASCULAR BIOGENICS LTD - COM (VBLT) as of Q2 2023
As of 30 Jun 2023,
VASCULAR BIOGENICS LTD - COM (VBLT) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
744,940 shares.
The largest 10 holders included
MORGAN STANLEY, GROUP ONE TRADING, L.P., Virtu Financial LLC, GEODE CAPITAL MANAGEMENT, LLC, CATALYST FINANCIAL PARTNERS LLC, TWO SIGMA INVESTMENTS, LP, OSAIC HOLDINGS, INC., HBK Sorce Advisory LLC, Spectrum Planning & Advisory Services Inc., and HRT FINANCIAL LP.
This page lists
16
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.